BioCGT Investor
@biocgtinvestor.bsky.social
Originally a Biologist, M.Sc in Biomedicine, PhD in Bioengineering, and +20 years experience in the research and development of novel Cell & Gene Therapies (CGT) tackling several clinical needs.
Follow me to get my analysis of the HealthCare sector
Follow me to get my analysis of the HealthCare sector
Hello everyone, check out my latest deep dive on allogeneic CAR-Ts, the competitive landscape and investor potential. Please share/like/follow #CART #Cancer #autoimmune #immunetherapy #science #celltherapy #finance #investment #bullish #ALLO #Allogene #SeekingAlpha seekingalpha.com/article/4762...
seekingalpha.com
February 26, 2025 at 4:03 PM
Hello everyone, check out my latest deep dive on allogeneic CAR-Ts, the competitive landscape and investor potential. Please share/like/follow #CART #Cancer #autoimmune #immunetherapy #science #celltherapy #finance #investment #bullish #ALLO #Allogene #SeekingAlpha seekingalpha.com/article/4762...
Hello BlueSky community, I am excited to share my views on the latest updates on the #Pharma #Biotech #MedTech industry with all of you. Check out my #Substack open.substack.com/pub/biocgtin... and my #SeekingAlpha seekingalpha.com/author/biocg... to get the full #financial and #technology analysis
BioCGT Investor’s Substack | BioCGT_Investor | Substack
As analyst, I will be focusing on analysing biotechnology, pharmaceutical, Medtech and healthcare stocks, providing you with my view of the company. Click to read BioCGT Investor’s Substack, by BioCGT...
open.substack.com
February 23, 2025 at 11:24 AM
Hello BlueSky community, I am excited to share my views on the latest updates on the #Pharma #Biotech #MedTech industry with all of you. Check out my #Substack open.substack.com/pub/biocgtin... and my #SeekingAlpha seekingalpha.com/author/biocg... to get the full #financial and #technology analysis